Phase 3 RECONNECT trials For example, two randomized, placebo-controlled Phase 3 trials evaluated as-needed bremelanotide in premenopausal women with HSDD
Pros: Can dramatically reduce brand-name costs FDA-approved medications No compounding involved Cons: Eligibility is inconsistent and hard to predict Programs can change or end without warning Often requires some form of insurance (even without coverage for the specific drug) Still expensive for many patients even with savings cards How We Evaluated For uninsured patients, we adjusted our evaluation criteria to emphasize what matters most when you're paying entirely out of pocket: Not sure which GLP-1 is right for you
DOI: 10.1038/s41574-025-01171-3 [Google Scholar] Li YK, Ma DX, Wang ZM, Hu XF, Li SL, Tian HZ, et al
it affects electrolyte transport across the intestinal mucosa and enhances colonic transport and motility
Trial Summary Table Enrollment across the nine numbered TRIUMPH trials is roughly 8,600 participants
Increased Fermentation When food moves through the gut more slowly, it spends more time in contact with intestinal bacteria